Seronegative antiphospholipid syndrome
Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review
An unusual cause of acute renal failure in systemic sclerosis
A fibrin based model for rheumatoid synovitis
p53 in rheumatoid arthritis synovial fibroblasts at sites of invasion
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
Switching from NSAIDs to paracetamol: a series of n of 1 trials for individual patients with osteoarthritis
Does hydrotherapy improve strength and physical function in patients with osteoarthritis—a randomised controlled trial comparing a gym based and a hydrotherapy based strengthening programme
Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study
Quality of life and work in patients with rheumatoid arthritis and ankylosing spondylitis of working age
Cancer incidence among patients with ankylosing spondylitis in Sweden 1965–95: a population based cohort study
EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT)
Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor α blockers can make sense
Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study
Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren’s syndrome: a randomised 12 week controlled study
Secondary Raynaud’s syndrome following radiotherapy
Sequence variations in the collagen IX and XI genes are associated with degenerative lumbar spinal stenosis
Osteocyte viability with glucocorticoid treatment: relation to histomorphometry
Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study
Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis
Serum human cartilage glycoprotein 39 as a marker of arthritis associated with inflammatory bowel disease
Distribution of lymphatic vessels in normal and arthritic human synovial tissues
Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis
Sexual dimorphism in the osteoarthritis of STR/ort mice may be linked to articular cytokines
Involvement of the omentum in Wegener’s granulomatosis
Infliximab in refractory spondyloarthropathies: a multicentre 38 week open study
High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and anti-tumour necrosis factor inhibitors
Insurance problems among patients with ankylosing spondylitis
Anti-tumour necrosis factor α treatment in chronic recurrent inflammation of the anterior segment of the eye in patients resistant to standard immunomodulatory treatment
Syncope in a patient with relapsing polychondritis
European Union of Medical Specialists (UEMS): Section of Rheumatology, and European Board of Rheumatology (EBR)
EULAR international liaison activities
EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT)
Standing Committee for Education and Training
Health Professionals Committee: key activities 2002–3
EULAR Standing Committee on Paediatric Rheumatology: 2003
Social Leagues Committee: key activities 2002–3
EULAR Standing Committee of Investigative Rheumatology: report of activities 2002–3
EULAR Standing Committee of Investigative Rheumatology: report of activities 2002–3
EULAR Standing Committee of Investigative Rheumatology: report of activities 2002–3
EULAR Standing Committee of Investigative Rheumatology: report of activities 2002–3
EULAR Standing Committee of Investigative Rheumatology: report of activities 2002–3
EULAR Standing Committee of Investigative Rheumatology: report of activities 2002–3
EULAR NEWS
EULAR NEWS